Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Croteau, D.
Right arrow Articles by Rogers, L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Croteau, D.
Right arrow Articles by Rogers, L. R.
Related Collections
Right arrow Chorea
Right arrow All Oncology
Right arrow Chemotherapy-tumor
Right arrow Paraneoplastic syndrome
Neurology 2001;57:719-722
© 2001 American Academy of Neurology
Brief Communications

Response to cancer therapy in a patient with a paraneoplastic choreiform disorder

David Croteau, MD, FRCP(C);, Alaa Owainati, MD, PhD;, Josep Dalmau, MD, PhD; and Lisa R. Rogers, DO

From the Departments of Neurosurgery (Drs. Croteau and Rogers) and Neurology (Dr. Rogers), Henry Ford Hospital, Detroit; and Department of Medical Oncology (Dr. Owainati), Oakland Medical Center, Pontiac, MI; and Department of Neurology (Dr. Dalmau), University of Arkansas for Medical Sciences, Little Rock.

Address correspondence and reprint requests to Dr. L.R. Rogers, Department of Neurology, Henry Ford Hospital, 2799 W. Grand Boulevard, Detroit, MI 48202.

The authors report a patient with chorea and multifocal neurologic abnormalities associated with a small-cell lung carcinoma. A previously unreported antibody directed at a 76-kD neuronal protein antigen was identified in both serum and CSF. Antitumor treatment resulted in dramatic and sustained clinical neurologic and serologic responses.




This article has been cited by other articles:


Home page
 In VivoHome page
A. ARDAVANIS, D. SYKOUTRI, P. KOUNTOURAKIS, D. DOUFEXIS, D. KORKOLIS, H. TZERBINI, I. SKARLATOS, E. MOSA, and G. RIGATOS
Paraneoplastic Cerebellar Degeneration in a Patient with Pseudomyxoma Peritonei and Breast Cancer: Case Report and Literature Review
In Vivo, September 1, 2009; 23(5): 835 - 838.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. G. Spiro, M. K. Gould, and G. L. Colice
Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 149S - 160S.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. B. Darnell and J. B. Posner
Paraneoplastic Syndromes Involving the Nervous System
N. Engl. J. Med., October 16, 2003; 349(16): 1543 - 1554.
[Full Text] [PDF]

Home page
 ChestHome page
M. A. Beckles, S. G. Spiro, G. L. Colice, and R. M. Rudd
Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes
Chest, January 1, 2003; 123 (2009): 97S - 104S.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncologyHome page
I. W. Tremont-Lukats, G. N. Fuller, T. Ribalta, P. Giglio, and M. D. Groves
Paraneoplastic chorea: Case study with autopsy confirmation
Neuro Oncology, July 1, 2002; 4(3): 192 - 195.
[Abstract] [PDF]